Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2020
  2. Published
  3. Published
  4. Published

    ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide

    Malmström, A., Łysiak, M., Åkesson, L., Jakobsen, I., Mudaisi, M., Milos, P., Hallbeck, M., Fomichov, V., Broholm, H., Grunnet, K., Poulsen, H. S., Bratthäll, C., Strandeus, M., Papagiannopoulou, A., Stenmark-Askmalm, M., Green, H. & Söderkvist, P., Apr 2020, In : The pharmacogenomics journal. 20, 2, p. 213-219 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. E-pub ahead of print

    Health-related quality of life and caregiver perspectives in glioblastoma survivors: a mixed-methods study

    Piil, K., Christensen, I. J., Grunnet, K. & Poulsen, H. S., 2020, In : BMJ Supportive and Palliative Care. p. epub

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. 2019
  7. Published
  8. Published
  9. Published

    VEGF-C as a putative therapeutic target in cancer

    Michaelsen, S. R., Poulsen, H. S. & Hamerlik, P., 18 Jun 2019, In : Oncotarget. 10, 40, p. 3988-3990 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma

    Shraibman, B., Barnea, E., Kadosh, D. M., Haimovich, Y., Slobodin, G., Rosner, I., López-Larrea, C., Hilf, N., Kuttruff, S., Song, C., Britten, C., Castle, J., Kreiter, S., Frenzel, K., Tatagiba, M., Tabatabai, G., Dietrich, P-Y., Dutoit, V., Wick, W., Platten, M., Winkler, F., von Deimling, A., Kroep, J., Sahuquillo, J., Martinez-Ricarte, F., Rodon, J., Lassen, U., Ottensmeier, C., van der Burg, S. H., Thor Straten, P., Poulsen, H. S., Ponsati, B., Okada, H., Rammensee, H-G., Sahin, U., Singh, H. & Admon, A., Jun 2019, 1 p.

    Research output: Other contributionResearch

  11. Published

    Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma

    Hilf, N., Kuttruff-Coqui, S., Frenzel, K., Bukur, V., Stevanović, S., Gouttefangeas, C., Platten, M., Tabatabai, G., Dutoit, V., van der Burg, S. H., Straten, P. T., Martinez-Ricarte, F., Ponsati, B., Okada, H., Lassen, U., Admon, A., Ottensmeier, C. H., Ulges, A., Kreiter, S., von Deimling, A., Skardelly, M., Migliorini, D., Kroep, J. R., Idorn, M., Rodon, J., Piro, J., Poulsen, H. S., Shraibman, B., McCann, K., Mendrzyk, R., Lower, M., Stieglbauer, M., Britten, C. M., Capper, D., Welters, M. J. P., Sahuquillo, J., Kiesel, K., Derhovanessian, E., Rusch, E., Bunse, L., Song, C., Heesch, S., Wagner, C., Kemmer-Bruck, A., Ludwig, J., Castle, J. C., Schoor, O., Tadmor, A. D., Green, E., Fritsche, J., Meyer, M., Pawlowski, N., Dorner, S., Hoffgaard, F., Rossler, B., Maurer, D., Weinschenk, T., Reinhardt, C., Huber, C., Rammensee, H-G., Singh-Jasuja, H., Sahin, U., Dietrich, P-Y. & Wick, W., Feb 2019, In : Nature. 566, 7745, p. E13

    Research output: Contribution to journalJournal articleResearch

  12. Published

    Actively personalized vaccination trial for newly diagnosed glioblastoma

    Hilf, N., Kuttruff-Coqui, S., Frenzel, K., Bukur, V., Stevanović, S., Gouttefangeas, C., Platten, M., Tabatabai, G., Dutoit, V., van der Burg, S. H., Thor Straten, P., Martínez-Ricarte, F., Ponsati, B., Okada, H., Lassen, U., Admon, A., Ottensmeier, C. H., Ulges, A., Kreiter, S., von Deimling, A., Skardelly, M., Migliorini, D., Kroep, J. R., Idorn, M., Rodon, J., Piró, J., Poulsen, H. S., Shraibman, B., McCann, K., Mendrzyk, R., Löwer, M., Stieglbauer, M., Britten, C. M., Capper, D., Welters, M. J. P., Sahuquillo, J., Kiesel, K., Derhovanessian, E., Rusch, E., Bunse, L., Song, C., Heesch, S., Wagner, C., Kemmer-Brück, A., Ludwig, J., Castle, J. C., Schoor, O., Tadmor, A. D., Green, E., Fritsche, J., Meyer, M., Pawlowski, N., Dorner, S., Hoffgaard, F., Rössler, B., Maurer, D., Weinschenk, T., Reinhardt, C., Huber, C., Rammensee, H-G., Singh-Jasuja, H., Sahin, U., Dietrich, P-Y. & Wick, W., 10 Jan 2019, In : Nature. 565, 7738, p. 240-245 6 p.

    Research output: Contribution to journalLetterResearchpeer-review

  13. Published

    Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

    Shraibman, B., Barnea, E., Kadosh, D. M., Haimovich, Y., Slobodin, G., Rosner, I., López-Larrea, C., Hilf, N., Kuttruff, S., Song, C., Britten, C., Castle, J., Kreiter, S., Frenzel, K., Tatagiba, M., Tabatabai, G., Dietrich, P-Y., Dutoit, V., Wick, W., Platten, M., Winkler, F., von Deimling, A., Kroep, J., Sahuquillo, J., Martinez-Ricarte, F., Rodon, J., Lassen, U., Ottensmeier, C., van der Burg, S. H., Thor Straten, P., Poulsen, H. S., Ponsati, B., Okada, H., Rammensee, H-G., Sahin, U., Singh, H. & Admon, A., 1 Jan 2019, In : Molecular & cellular proteomics : MCP. 18, 6, p. 1255-1268 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published
  15. Published

    Extracranial metastases in glioblastoma-Two case stories

    Schou Nørøxe, D., Regner Michaelsen, S., Broholm, H., Møller, S., Skovgaard Poulsen, H. & Lassen, U., 2019, In : Clinical Case Reports. 7, 2, p. 289-294 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published
  17. Published
  18. 2018
  19. Published

    Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine

    Galldiks, N., Dunkl, V., Ceccon, G., Tscherpel, C., Stoffels, G., Law, I., Henriksen, O. M., Muhic, A., Poulsen, H. S., Steger, J., Bauer, E. K., Lohmann, P., Schmidt, M., Shah, N. J., Fink, G. R. & Langen, K-J., Dec 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 13, p. 2377-2386 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival

    Michaelsen, S. R., Urup, T., Olsen, L. R., Broholm, H., Lassen, U. & Poulsen, H. S., May 2018, In : Journal of Neuro-Oncology. 137, 3, p. 533-542 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B

    Staberg, M., Rasmussen, R. D., Michaelsen, S. R., Pedersen, H., Jensen, K. E., Villingshøj, M., Skjoth-Rasmussen, J., Brennum, J., Vitting-Seerup, K., Poulsen, H. S. & Hamerlik, P., Mar 2018, In : Molecular Oncology. 12, 3, p. 406-420 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas

    Michaelsen, S. R., Aslan, D., Urup, T., Poulsen, H. S., Grønbæk, K., Broholm, H. & Kristensen, L. S., 28 Feb 2018, In : International Journal of Molecular Sciences. 19, 3, p. 679 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published
  24. Published
  25. Published

    Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors

    Johansen, M. D., Urup, T., Holst, C. B., Christensen, I. J., Grunnet, K., Lassen, U., Friis, S. & Poulsen, H. S., 2018, In : Cancer Investigation. 36, 9-10, p. 512-519 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis

    Dahlrot, R. H., Dowsett, J., Fosmark, S., Malmström, A., Henriksson, R., Boldt, H., de Stricker, K., Sørensen, M. D., Poulsen, H. S., Lysiak, M., Söderkvist, P., Rosell, J., Hansen, S. & Kristensen, B. W., 2018, In : Neuropathology and Applied Neurobiology. 44, 2, p. 172-184

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published
  28. Published
  29. Published

    VEGF-C Sustains VEGFR2 Activation under Bevacizumab Therapy and Promotes Glioblastoma Maintenance

    Michaelsen, S. R., Staberg, M., Pedersen, H., Jensen, K. E., Majewski, W., Broholm, H., Nedergaard, M. K., Meulengracht, C., Urup, T., Villingshøj, M., Lukacova, S., Skjøth-Rasmussen, J., Brennum, J., Kjær, A., Lassen, U., Stockhausen, M-T., Poulsen, H. S. & Hamerlik, P., 2018, In : Neuro-Oncology. 20, 11, p. 1462-74

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. 2017
  31. Published

    Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

    Urup, T., Staunstrup, L. M., Michaelsen, S. R., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Olsen, L. R., Jønson, L., Issazadeh-Navikas, S., Broholm, H., Hamerlik, P., Poulsen, H. S. & Lassen, U., 18 Apr 2017, In : B M C Cancer. 17, 1, p. e278

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published
  33. Published
  34. Published

    Hallmarks of glioblastoma: a systematic review

    Nørøxe, D. S., Poulsen, H. S. & Lassen, U., 22 Feb 2017, In : ESMO Open. 1, 6, p. e000144

    Research output: Contribution to journalReviewResearchpeer-review

  35. Published

    Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine

    Staberg, M., Michaelsen, S. R., Rasmussen, R. D., Villingshøj, M., Poulsen, H. S. & Hamerlik, P., Feb 2017, In : Cellular oncology (Dordrecht). 40, 1, p. 21–32 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    ABCB1 genotype predictive for survival in glioblastoma treated with radiotherapy and concomitant temozolomide

    Malmström, A., Lysiak, M., Hallbeck, M., Falk, I. J., Åkesson, L., Broholm, H., Mudaisi, M., Milos, P., Fomichov, V., Bratthäll, C., Strandeus, M., Papagiannopoulou, A., Poulsen, H. S., Stenmark-Askmalm, M., Gréen, H. & Söderkvist, P., 2017.

    Research output: Contribution to conferencePosterResearchpeer-review

  37. Published

    Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial

    Malmström, A., Poulsen, H. S., Grønberg, B. H., Stragliotto, G., Hansen, S., Asklund, T., Holmlund, B., Łysiak, M., Dowsett, J., Kristensen, B. W., Söderkvist, P., Rosell, J., Henriksson, R. & Nordic Clinical Brain Tumor Study Group (NCBTSG), 2017, In : Acta oncologica . 56, 12, p. 1776-1785

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published
  39. 2016
  40. Published

    A comprehensive profile of recurrent glioblastoma

    Campos, B., Olsen, L. R., Urup, T. & Poulsen, H. S., 10 Nov 2016, In : Oncogene. 35, 45, p. 5819-5825 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients

    Urup, T., Michaelsen, S. R., Olsen, L. R., Toft, A., Christensen, I. J., Grunnet, K., Winther, O., Broholm, H., Kosteljanetz, M., Issazadeh-Navikas, S., Poulsen, H. S. & Lassen, U., Oct 2016, In : Molecular Oncology. 10, 8, p. 1160-1168

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published
  43. Published
  44. Published
  45. Published
  46. Published
  47. Published
  48. Published

    Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients

    Urup, T., Michaelsen, S. R., Olsen, L. R., Toft, A., Christensen, I. J., Grunnet, K., Winther, O., Broholm, H., Kosteljanetz, M., Issazadeh-Navikas, S., Poulsen, H. S. & Lassen, U., 2016.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  49. Published
  50. Published

    Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients

    Urup, T., Michaelsen, S. R., Staunstrup, L. M., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Jønson, L., Broholm, H., Hamerlik, P., Poulsen, H. S. & Lassen, U., 2016.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  51. Published
  52. Published
  53. Published

    Quantitative and allelic methylation analyses of MGMT in gliobastoma

    Kristensen, L. S., Michaelsen, S. R., Dyrbye, H., Aslan, D., Grunnet, K., Christensen, I. J., Poulsen, H. S., Grønbæk, K. & Broholm, H., 2016.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  54. Published

    VEGF-C contributes to autocrine VEGF Receptor 2 signaling and cellular maintenance in glioblastoma

    Michaelsen, S. R., Nedergaard, M. K., Broholm, H., Bartkova, J., Staberg, M., Urup, T., Aghi, M., Lucacova, S., Villingshøj, M., Pedersen, P., Kjær, A., Perryman, L., Erler, J. T., Bartek, J., Lassen, U., Stockhausen, M., Poulsen, H. S. & Hamerlik, P., 2016.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  55. 2015
  56. Published
Previous 1 2 Next

ID: 12457